GE HealthCare Technologies Inc. $GEHC Holdings Lowered by Principal Financial Group Inc.

Principal Financial Group Inc. lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 31.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 542,699 shares of the company’s stock after selling 247,358 shares during the period. Principal Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $40,757,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. True North Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 2.0% during the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after acquiring an additional 139 shares during the period. Klingman & Associates LLC lifted its holdings in shares of GE HealthCare Technologies by 4.0% in the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after purchasing an additional 139 shares in the last quarter. Golden State Wealth Management LLC boosted its position in shares of GE HealthCare Technologies by 7.4% in the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after buying an additional 148 shares during the period. Exchange Traded Concepts LLC grew its holdings in shares of GE HealthCare Technologies by 1.3% during the third quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock valued at $863,000 after buying an additional 150 shares in the last quarter. Finally, Modera Wealth Management LLC raised its position in GE HealthCare Technologies by 3.5% during the second quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock valued at $333,000 after buying an additional 152 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 0.4%

GEHC stock opened at $82.31 on Friday. The firm has a market cap of $37.49 billion, a PE ratio of 18.05, a PEG ratio of 2.46 and a beta of 1.08. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a fifty day simple moving average of $82.72 and a 200 day simple moving average of $77.50. The company has a current ratio of 1.37, a quick ratio of 0.95 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s revenue was up 7.1% compared to the same quarter last year. During the same period last year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on GEHC shares. Barclays set a $87.00 target price on GE HealthCare Technologies in a research note on Friday. Wells Fargo & Company lifted their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Jefferies Financial Group boosted their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, GE HealthCare Technologies currently has an average rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.